SEARCH

SEARCH BY CITATION

References

  • 1
    Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res 2011;343:5783.
  • 2
    Lee JJ, Lee NA. Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? Clin Exp Allergy 2005;35:986994.
  • 3
    Gupta SK, Haigh BJ, Griffin FJ, Wheeler TT. The mammalian secreted RNases: mechanisms of action in host defence. Innate Immun 2012;19:8697.
  • 4
    Rosenberg HF, Domachowske JB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 2001;70:691698.
  • 5
    McLaren DJ, McKean JR, Olsson I, Venges P, Kay AB. Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol 1981;3:359373.
  • 6
    Ackerman SJ, Gleich GJ, Loegering DA, Richardson BA, Butterworth AE. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg 1985;34:735745.
  • 7
    Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008;14:949953.
  • 8
    Bystrom J, Amin K, Bishop-Bailey D. Analysing the eosinophil cationic protein-a clue to the function of the eosinophil granulocyte. Respir Res 2011;12:10.
  • 9
    El-Shazly A, Masuyama K, Nakano K, Eura M, Samejima Y, Ishikawa T. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. Int Arch Allergy Immunol 1998;117(Suppl 1):5558.
  • 10
    Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 2000;95:19111917.
  • 11
    Shamri R, Melo RC, Young KM, Bivas-Benita M, Xenakis JJ, Spencer LA et al. CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules. Faseb J 2012;26:20842093.
  • 12
    Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:14251431.
  • 13
    Wang HB, Ghiran I, Matthaei K, Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 2007;179:75857592.
  • 14
    Akuthota P, Shamri R, Weller PF. Isolation of human eosinophils. Curr Protoc Immunol 2012;98:7.31.17.31.8.
  • 15
    Driessens MH, van Hulten P, Zuurbier A, La Riviere G, Roos E. Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18. Evidence that the LFA-1 binding sites for ICAM-1, -2, and -3 are distinct. J Leukoc Biol 1996;60:758765.
  • 16
    Shamri R, Grabovsky V, Gauguet JM, Feigelson S, Manevich E, Kolanus W et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 2005;6:497506.
  • 17
    Boix E. Eosinophil cationic protein. Methods Enzymol 2001;341:287305.
  • 18
    Zimmermann N, Hogan SP, Mishra A, Brandt EB, Bodette TR, Pope SM et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 2000;165:58395846.
  • 19
    White JR, Lee JM, Dede K, Imburgia CS, Jurewicz AJ, Chan G et al. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. J Biol Chem 2000;275:3662636631.
  • 20
    Boehme SA, Sullivan SK, Crowe PD, Santos M, Conlon PJ, Sriramarao P et al. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol 1999;163:16111618.
  • 21
    Curnock AP, Logan MK, Ward SG. Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology 2002;105:125136.
  • 22
    Pinho V, Souza DG, Barsante MM, Hamer FP, De Freitas MS, Rossi AG et al. Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J Leukoc Biol 2005;77:800810.
  • 23
    Wong CK, Cheung PF, Ip WK, Lam CW. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 2007;37:8596.
  • 24
    Mishra RK, Scaife JE, Harb Z, Gray BC, Djukanovic R, Dent G. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). Allergy 2005;60:12041207.
  • 25
    Yamamura K, Adachi T, Masuda T, Kojima Y, Hara A, Toda T et al. Intracellular protein phosphorylation in eosinophils and the functional relevance in cytokine production. Int Arch Allergy Immunol 2009;149(Suppl 1):4550.
  • 26
    Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994;152:54575467.
  • 27
    Anwar AR, Walsh GM, Cromwell O, Kay AB, Wardlaw AJ. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology 1994;82:222228.
  • 28
    Munoz NM, Hamann KJ, Rabe KF, Sano H, Zhu X, Leff AR. Augmentation of eosinophil degranulation and LTC(4) secretion by integrin-mediated endothelial cell adhesion. Am J Physiol 1999;277:L802L810.
  • 29
    Saito K, Nagata M, Kikuchi I, Sakamoto Y. Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via beta2 integrin. Ann Allergy Asthma Immunol 2004;93:594600.
  • 30
    Lenter M, Uhlig H, Hamann A, Jeno P, Imhof B, Vestweber D. A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1. Proc Natl Acad Sci USA 1993;90:90519055.
  • 31
    Brock C, Schaefer M, Reusch HP, Czupalla C, Michalke M, Spicher K et al. Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. J Cell Biol 2003;160:8999.
  • 32
    Bates ME, Green VL, Bertics PJ. ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesis. J Biol Chem 2000;275:1096810975.
  • 33
    Xu X, Hakansson L. Regulation of the release of eosinophil cationic protein by eosinophil adhesion. Clin Exp Allergy 2000;30:794806.
  • 34
    Adamko DJ, Wu Y, Ajamian F, Ilarraza R, Moqbel R, Gleich GJ. The effect of cationic charge on release of eosinophil mediators. J Allergy Clin Immunol 2008;122:383390.
  • 35
    Sedgwick JB, Jansen KJ, Kennedy JD, Kita H, Busse WW. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions. J Allergy Clin Immunol 2005;116:812819.
  • 36
    Kaneko M, Horie S, Kato M, Gleich GJ, Kita H. A crucial role for beta 2 integrin in the activation of eosinophils stimulated by IgG. J Immunol 1995;155:26312641.
  • 37
    Kato M, Abraham RT, Okada S, Kita H. Ligation of the beta2 integrin triggers activation and degranulation of human eosinophils. Am J Respir Cell Mol Biol 1998;18:675686.
  • 38
    Kato M, Kimura H, Tachibana A, Motegi Y, Tokuyama K, Kita H et al. Intracellular signaling pathways in human eosinophil activation: role of a beta2 integrin, alphaMbeta2. Int Arch Allergy Immunol 1999;120(Suppl 1):5153.
  • 39
    Walsh GM, Wardlaw AJ. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin. J Allergy Clin Immunol 1997;100:208215.